BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 14770243)

  • 21. Synthesis and structure-activity relationships of new benzodioxinic lactones as potential anticancer drugs.
    Romero M; Renard P; Caignard DH; Atassi G; Solans X; Constans P; Bailly C; Pujol MD
    J Med Chem; 2007 Jan; 50(2):294-307. PubMed ID: 17228871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and structural characterization of derivatives of 2- and 3-benzo[b]furan carboxylic acids with potential cytotoxic activity.
    Kossakowski J; Ostrowska K; Hejchman E; Wolska I
    Farmaco; 2005; 60(6-7):519-27. PubMed ID: 15950225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 2-Phenylbenzo[b]furans: relationship between structure, estrogen receptor affinity and cytostatic activity against mammary tumor cells.
    Erber S; Ringshandl R; von Angerer E
    Anticancer Drug Des; 1991 Nov; 6(5):417-26. PubMed ID: 1764164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthetic studies on selective adenosine A2A receptor antagonists. Part II: synthesis and structure-activity relationships of novel benzofuran derivatives.
    Saku O; Saki M; Kurokawa M; Ikeda K; Uchida S; Takizawa T; Uesaka N
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3768-71. PubMed ID: 20483600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytotoxic activity and cytostatic mechanism of novel 2-arylbenzo[b]furans.
    Yang H; Pang JY; Cai YC; Xu ZL; Xian LJ
    J Pharm Pharmacol; 2006 Sep; 58(9):1281-7. PubMed ID: 16945188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substituted naphthofurans as hallucinogenic phenethylamine-ergoline hybrid molecules with unexpected muscarinic antagonist activity.
    Monte AP; Marona-Lewicka D; Lewis MM; Mailman RB; Wainscott DB; Nelson DL; Nichols DE
    J Med Chem; 1998 Jun; 41(12):2134-45. PubMed ID: 9622555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Synthesis of 2-, 4- and 5-(2-alkylcarbamoyl-1-methylvinyl)-7-alkyloxybenzo[b]furans and their leukotriene B4 receptor antagonistic activity].
    Ando K
    Yakugaku Zasshi; 2005 Nov; 125(11):863-74. PubMed ID: 16272807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A photochemical route to 2-substituted benzo[b]furans.
    Protti S; Fagnoni M; Albini A
    J Org Chem; 2012 Aug; 77(15):6473-9. PubMed ID: 22774767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel cyano- and N-isopropylamidino-substituted derivatives of benzo[b]thiophene-2-carboxanilides and benzo[b]thieno[2,3-c]quinolones: synthesis, photochemical synthesis, crystal structure determination, and antitumor evaluation. 2.
    Jarak I; Kralj M; Suman L; Pavlović G; Dogan J; Piantanida I; Zinić M; Pavelić K; Karminski-Zamola G
    J Med Chem; 2005 Apr; 48(7):2346-60. PubMed ID: 15801828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis and docking studies of new furobenzopyranones and pyranobenzopyranones as photoreagent towards DNA and as antimicrobial agents.
    Farag NA; El-Tayeb W
    Eur J Med Chem; 2010 Jan; 45(1):317-25. PubMed ID: 19897282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benzo[b]thiophene-2-carboxamides and benzo[b]furan-2-carboxamides are potent antagonists of the human H3-receptor.
    Peschke B; Bak S; Hohlweg R; Nielsen R; Viuff D; Rimvall K
    Bioorg Med Chem Lett; 2006 Jun; 16(12):3162-5. PubMed ID: 16616493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and antimicrobial activity of some novel derivatives of benzofuran: part 1. Synthesis and antimicrobial activity of (benzofuran-2-yl)(3-phenyl-3-methylcyclobutyl) ketoxime derivatives.
    Koca M; Servi S; Kirilmis C; Ahmedzade M; Kazaz C; Ozbek B; Otük G
    Eur J Med Chem; 2005 Dec; 40(12):1351-8. PubMed ID: 16129517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and structure-activity relationships of ferrocenyl tamoxifen derivatives with modified side chains.
    Nguyen A; Top S; Pigeon P; Vessières A; Hillard EA; Plamont MA; Huché M; Rigamonti C; Jaouen G
    Chemistry; 2009; 15(3):684-96. PubMed ID: 19053086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regioselective preparation of benzo[b]furans from phenols and α-bromoketones.
    Arias L; Vara Y; Cossío FP
    J Org Chem; 2012 Jan; 77(1):266-75. PubMed ID: 22122090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonists.
    Baraldi PG; Fruttarolo F; Tabrizi MA; Preti D; Romagnoli R; El-Kashef H; Moorman A; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 2003 Mar; 46(7):1229-41. PubMed ID: 12646033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis, and structure-activity relationship of new isobenzofuranone ligands of protein kinase C.
    Baba Y; Ogoshi Y; Hirai G; Yanagisawa T; Nagamatsu K; Mayumi S; Hashimoto Y; Sodeoka M
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2963-7. PubMed ID: 15125969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-osteoporosis effect of 5-bromo-2-(4-chlorobenzoyl)-(Z)-3-(2-cyano-3-hydroxybut-2-enonyl)aminobenzo[b]furan: a novel selective estrogen receptor modulator.
    Fukuyama R; Shimokawa A; Kodama Y; Fujita M; Ohishi Y; Ando Y; Koida M; Nakamuta H
    J Pharmacol Sci; 2011; 116(2):214-20. PubMed ID: 21606624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thienopyridine and benzofuran derivatives as potent anti-tumor agents possessing different structure-activity relationships.
    Hayakawa I; Shioya R; Agatsuma T; Furukawa H; Sugano Y
    Bioorg Med Chem Lett; 2004 Jul; 14(13):3411-4. PubMed ID: 15177443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Syntheses and structure-activity relationships of novel retinoid X receptor agonists.
    Hibi S; Kikuchi K; Yoshimura H; Nagai M; Tai K; Hida T
    J Med Chem; 1998 Aug; 41(17):3245-52. PubMed ID: 9703470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-based drug design using GPCR homology modeling: toward the discovery of novel selective CysLT2 antagonists.
    Dong X; Zhao Y; Huang X; Lin K; Chen J; Wei E; Liu T; Hu Y
    Eur J Med Chem; 2013 Apr; 62():754-63. PubMed ID: 23455026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.